{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:41:42Z","timestamp":1784979702709,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","award":["JP18J20257"],"award-info":[{"award-number":["JP18J20257"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18ek0410035h0003"],"award-info":[{"award-number":["18ek0410035h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbrc.2025.152590","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T15:56:23Z","timestamp":1756914983000},"page":"152590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting PAR-2 in atopic dermatitis: Preclinical evaluation of the novel inhibitor E6795"],"prefix":"10.1016","volume":"782","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8727-4383","authenticated-orcid":false,"given":"Naomi","family":"Kitayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisa","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7365-947X","authenticated-orcid":false,"given":"Atsushi","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0773-0554","authenticated-orcid":false,"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152590_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2013.02.001","article-title":"New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity","volume":"70","author":"Kabashima","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.bbrc.2025.152590_bib2","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1096\/fj.02-1112com","article-title":"Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo","volume":"17","author":"Seeliger","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2025.152590_bib3","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3349\/ymj.2010.51.6.808","article-title":"Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis","volume":"51","author":"Lee","year":"2010","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.bbrc.2025.152590_bib4","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1523\/JNEUROSCI.23-15-06176.2003","article-title":"Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin","volume":"23","author":"Steinhoff","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2025.152590_bib5","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3389\/fimmu.2020.01740","article-title":"Protease-activated receptor-2 regulates neuro-epidermal communication in atopic dermatitis","volume":"11","author":"Buhl","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152590_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ncomms1162","article-title":"PAR2 absence completely rescues inflammation and ichthyosis caused by altered CAP1\/Prss8 expression in mouse skin","volume":"2","author":"Frateschi","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.152590_bib9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s42003-020-01504-0","article-title":"Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition","volume":"3","author":"Kennedy","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrc.2025.152590_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.jid.5700965","article-title":"Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases","volume":"128","author":"Stefansson","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbrc.2025.152590_bib11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/exd.13936","article-title":"Update on protease-activated receptor 2 in cutaneous barrier, differentiation, tumorigenesis and pigmentation, and its role in related dermatologic diseases","volume":"28","author":"Henehan","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bbrc.2025.152590_bib12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jid.2018.08.019","article-title":"PAR2 pepducin-based suppression of inflammation and itch in atopic dermatitis models","volume":"139","author":"Barr","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbrc.2025.152590_bib13","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3390\/jcm11102807","article-title":"Bruton's kinase inhibitors for the treatment of immunological diseases: current status and perspectives","volume":"11","author":"Robak","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrc.2025.152590_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1068260","article-title":"JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: an updated review","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152590_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0625.1999.tb00383.x","article-title":"Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase","volume":"8","author":"Steinhoff","year":"1999","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bbrc.2025.152590_bib16","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20082242","article-title":"Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome","volume":"206","author":"Briot","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2025.152590_bib17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.chembiol.2003.10.014","article-title":"Structural basis for thrombin activation of a protease-activated receptor: inhibition of intramolecular liganding","volume":"10","author":"Seeley","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbrc.2025.152590_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11882-007-0055-6","article-title":"Proteases as Th2 adjuvants","volume":"7","author":"Chapman","year":"2007","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.bbrc.2025.152590_bib19","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1398-9995.2009.02023.x","article-title":"Mite serine protease activates protease-activated receptor-2 and induces cytokine release in human keratinocytes","volume":"64","author":"Kato","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.bbrc.2025.152590_bib20","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1038\/sj.jid.5700351","article-title":"Serine protease signaling of epidermal permeability barrier homeostasis","volume":"126","author":"Hachem","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbrc.2025.152590_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","article-title":"The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch","volume":"155","author":"Wilson","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.152590_bib22","series-title":"Itch","first-page":"215","article-title":"Role of PAR-2 in neuroimmune communication and itch","author":"Liu","year":"2014"},{"key":"10.1016\/j.bbrc.2025.152590_bib23","first-page":"119","article-title":"Thymic stromal lymphopoietin production induced by skin irritation results from concomitant activation of protease-activated receptor 2 and interleukin 1 pathways","volume":"182","author":"Redhu","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbrc.2025.152590_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4062\/biomolther.2016.011","article-title":"Skin barrier recovery by protease-activated receptor-2 antagonist lobaric acid","volume":"24","author":"Joo","year":"2016","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.bbrc.2025.152590_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2018.05.016","article-title":"Novel peptide inhibits inflammation by suppressing of protease activated receptor-2","volume":"832","author":"Kim","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152590_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jep.2017.01.055","article-title":"Topical treatments of Saussurea costus root and Thuja orientalis L. synergistically alleviate atopic dermatitis-like skin lesions by inhibiting protease-activated receptor-2 and NF-\u03baB signaling in HaCaT cells and Nc\/Nga mice","volume":"199","author":"Yang","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbrc.2025.152590_bib27","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jaad.2017.12.022","article-title":"Dupilumab: a review of its use in the treatment of atopic dermatitis","volume":"78","author":"Gooderham","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bbrc.2025.152590_bib28","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s40265-022-01771-7","article-title":"Correction: tapinarof cream 1%: first approval","volume":"82","author":"Keam","year":"2022","journal-title":"Drugs"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25013051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25013051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:47:40Z","timestamp":1772826460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25013051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":26,"alternative-id":["S0006291X25013051"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152590","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting PAR-2 in atopic dermatitis: Preclinical evaluation of the novel inhibitor E6795","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152590"}}